Not applicableStudy completedNCT01632111What this trial is testingPulmonary Involvement in Patients With Fabry DiseaseWho this might be right forFabry Disease University of Zurich 110
Very early researchLooking for participantsNCT06458010What this trial is testingClinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)Who this might be right forFamilial Hypercholesterolemia RenJi Hospital 20
Post-approval studies (Phase 4)Study completedNCT00097890What this trial is testingReplagal Enzyme Replacement Therapy for Adults With Fabry DiseaseWho this might be right forFabry Disease National Institute of Neurological Disorders and Stroke (NINDS) 25
Not applicableLooking for participantsNCT05007990What this trial is testingCaregiving Networks Across Disease Context and the Life CourseWho this might be right forInherited Metabolic DisordersUndiagnosed DiseasesBatten's Disease+2 more National Human Genome Research Institute (NHGRI) 2,800
Post-approval studies (Phase 4)Study completedNCT00365131What this trial is testingStudy of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease.Who this might be right forGaucher Disease Type ICerebroside Lipidosis SyndromeClucocerebrosidase Deficiency Disease+2 more Genzyme, a Sanofi Company 40
Not applicableStudy completedNCT07090629What this trial is testingThe Benefits of the Measureof Epicardial Adipose Tissue During Coronary Calcium Assessment of the Refine Cardiovascular Risk Assessment at Reunion Island.Who this might be right forHigh CholesterolLipodystrophy, Familial PartialDiabetes Centre Hospitalier Universitaire de la Réunion 126
Testing effectiveness (Phase 2)Study completedNCT00519363What this trial is testingStatins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like ReceptorsWho this might be right forSystemic Lupus Erythematosus The Center for Rheumatic Disease, Allergy, & Immunology 15
Not applicableEnded earlyNCT02345421What this trial is testingIdentify and Characterize LAL-D Patients in High-risk PopulationsWho this might be right forLysosomal Acid Lipase Deficiency Alexion Pharmaceuticals, Inc. 640
Not applicableStudy completedNCT00001721What this trial is testingStudy of Smith-Lemli-Opitz SyndromeWho this might be right forSmith-Lemli-Opitz Syndrome Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 130
Not applicableWithdrawnNCT02778295What this trial is testingBiomarker for Patients With Fabry Disease (BioFabry)Who this might be right forAngiokeratomasChronic Kidney DiseaseOcular Abnormalities+1 more CENTOGENE GmbH Rostock
Large-scale testing (Phase 3)Ended earlyNCT04395339What this trial is testingGM1 Prophylaxis for WBRT Related Cognitive DysfunctionWho this might be right forBrain MetastasesRadiotherapy Side EffectCognitive Impairment+2 more Sun Yat-sen University 51
Not applicableLooking for participantsNCT07716488What this trial is testingScreening for Disorders of Lipid Metabolism and Familial Hyperlipidemia in Children and Adolescents With Increased Cardiovascular Risk Due to Chronic Diseases Such as Congenital Heart Disease, Chronic Inflammatory Bowel Disease, Celiac Disease and Rheumatic DisordersWho this might be right forLipid Metabolism DisordersLipid Metabolism, Inborn ErrorsCongenital Heart Disease+4 more Alexandra Miriam Kiess 600
Not applicableLooking for participantsNCT06439654What this trial is testingAtlantic Lipid Lowering Treatment Optimization ProgramWho this might be right forFamilial HypercholesterolemiaLipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaApolipoprotein B 100, Familial Defective+2 more Atlantic Health System 250
Early research (Phase 1)Study completedNCT01603186What this trial is testingBioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed ConditionWho this might be right forFed IPCA Laboratories Ltd. 54
Early research (Phase 1)Study completedNCT01437059What this trial is testingTrial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C)Who this might be right forElevated LDL-Cholesterol (LDL-C) Alnylam Pharmaceuticals 32
Not applicableStudy completedNCT03173495What this trial is testingEffects of Exercise on Fructose-induced Postprandial LipemiaWho this might be right forSedentary LifestyleDyslipidemiasLipid Metabolism Disorders+1 more Federal University of Rio Grande do Sul 12
Large-scale testing (Phase 3)Study completedNCT02585895What this trial is testingEvolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study EnrollmentWho this might be right forHypercholesterolemia Amgen 39
Not applicableStudy completedNCT01721187What this trial is testingSatiety Effects on the Neural Valuation of FoodWho this might be right forFastingFed Duke-NUS Graduate Medical School 60
Testing effectiveness (Phase 2)Ended earlyNCT03746587What this trial is testingStudy of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3Who this might be right forGaucher Disease, Type 1Gaucher Disease, Type 3 ZevraDenmark 39
Testing effectiveness (Phase 2)UnknownNCT00004293What this trial is testingPhase II Study of Glucocerebrosidase in Patients With Gaucher DiseaseWho this might be right forGaucher's Disease National Center for Research Resources (NCRR) 24